The World Health Organization has prequalified Coartem Baby, the first and only antimalarial for babies. Novartis developed this combination drug in partnership with Medicines for Malaria Venture.
Phase 3 results for the Novartis malaria drug “GanLum” show it was comparable to the standard of care and led to cure rates that top the threshold recommended by the World Health Organization. If approved, this new combination drug would become the first novel malaria therapy in more than 25 years.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Novartis malaria drug Coartem has expanded its approval to include babies. The combination drug, originally formulated as a tablet, has a new dose strength and formulation designed for treating newborns and young infants who develop malarial infections.
The company is releasing three types of maps meant to help public health organizations stay ahead of disease outbreaks and guide disaster response: population density maps, movement maps and network coverage maps.
AI tools for automating malaria detection, improving stroke care and predicting suicide risk are among the technologies Partners believes have the greatest potential to impact healthcare in the next year.
European regulators have approved the first malaria vaccine that has the potential to save thousands of infants from contracting the killer disease, Anthem formally agreed to buy Cigna for $48.4 billion now there's just the potential antitrust issues to sweat through.
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Laser technology to diagnose malaria — one of the world’s deadliest diseases — succeeded in early trials. Rice University researchers tested an experimental laser device that can diagnose malaria in a few seconds. The ultra-rapid diagnostic may offer substantial cost savings in global efforts to combat malaria . The study has been published in the […]
Over a million people each year die from diseases transmitted by mosquitoes, like malaria, Chikungunya, Dengue Fever, and Yellow Fever. Tackling this problem is a challenge, but Oxitec, a British biotech company, is developing mosquitoes that have been genetically altered in order to potentially change the progress of the situation. Tests with mosquitoes in Brazil […]
Biotech company Sanaria has spent the last decade working on a malaria vaccine that in early tests has shown tremendous potential to protect people from the deadly infection transmitted by mosquitoes. Now, to scale up, it’s turning to the crowd to fund a robot that would speed up part of the production process by 20 […]
A “handheld laboratory” designed to diagnose malaria in under 15 minutes could be in the hands of healthcare workers overseas within two years if QuantuMDx can meet the ambitious goals it’s set for itself. The medical device company has turned to Indiegogo in search of $50,000 for field trials of its miniaturized DNA sequencing device. […]
When Brian Grimberg and a team at Case Western Reserve University began working on their Rapid Assessment of Malaria (RAM) device nearly four years ago, it was the size of a kitchen table. Today, the functional prototype is a handheld device that the team thinks can diagnose the tropical disease more quickly, simply and affordably. […]
We’ve looked extensively at how hospitals, pharmaceutical companies, entrepreneurs, doctors, patients and medical schools are using social media. But there’s another group whose inherently social nature lends itself well to social media success: health-related charitable organizations. From the Red Cross to the American Heart Association, most nonprofit organizations today have a strong online presence, but […]